These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 14517189

  • 1. Levosimendan: implications for clinicians.
    McBride BF, White CM.
    J Clin Pharmacol; 2003 Oct; 43(10):1071-81. PubMed ID: 14517189
    [Abstract] [Full Text] [Related]

  • 2. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C, Tousoulis D, Koumallos N, Marinou K, Stefanadis C.
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [Abstract] [Full Text] [Related]

  • 3. Levosimendan: a new option in acute cardiac failure.
    Holley AD, Ziegenfuss M.
    Emerg Med Australas; 2006 May; 18(5-6):505-9. PubMed ID: 17083641
    [No Abstract] [Full Text] [Related]

  • 4. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
    Earl GL, Fitzpatrick JT.
    Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
    [Abstract] [Full Text] [Related]

  • 5. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG, Nikitin N, McGowan J.
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
    [Abstract] [Full Text] [Related]

  • 6. Levosimendan and calcium sensitization of the contractile proteins in cardiac muscle: impact on heart failure.
    Kota B, Prasad AS, Economides C, Singh BN.
    J Cardiovasc Pharmacol Ther; 2008 Dec; 13(4):269-78. PubMed ID: 19087950
    [Abstract] [Full Text] [Related]

  • 7. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F.
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [Abstract] [Full Text] [Related]

  • 8. The utility of levosimendan in the treatment of heart failure.
    Lehtonen L, Põder P.
    Ann Med; 2007 May; 39(1):2-17. PubMed ID: 17364447
    [Abstract] [Full Text] [Related]

  • 9. A promising new inotrope: levosimendan.
    Fotbolcu H, Duman D.
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):176-82. PubMed ID: 20382619
    [Abstract] [Full Text] [Related]

  • 10. The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
    Cavana M, Pignataro C, Fraticelli A, Mebazaa A.
    Ital Heart J; 2003 May; 4 Suppl 2():61S-64S. PubMed ID: 14635372
    [Abstract] [Full Text] [Related]

  • 11. Newer inotropes in pediatric heart failure.
    Hoffman TM.
    J Cardiovasc Pharmacol; 2011 Aug; 58(2):121-5. PubMed ID: 21386708
    [Abstract] [Full Text] [Related]

  • 12. Levosimendan.
    Figgitt DP, Gillies PS, Goa KL.
    Drugs; 2001 Aug; 61(5):613-27; discussion 628-9. PubMed ID: 11368286
    [Abstract] [Full Text] [Related]

  • 13. Evidence-based use of levosimendan in different clinical settings.
    De Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M.
    Eur Heart J; 2006 Aug; 27(16):1908-20. PubMed ID: 16682381
    [Abstract] [Full Text] [Related]

  • 14. Levosimendan: a new approach for the treatment of patients with severe heart failure. A brief summary based on a clinical case.
    Morais J, Dias B, Pontes N.
    Rev Port Cardiol; 2003 Aug; 22(7-8):941-8. PubMed ID: 14587161
    [Abstract] [Full Text] [Related]

  • 15. Levosimendan: dual mechanisms for acute heart failure...and beyond?
    Ng TM, Akhter MW.
    Minerva Cardioangiol; 2005 Dec; 53(6):565-84. PubMed ID: 16333239
    [Abstract] [Full Text] [Related]

  • 16. Levosimendan: current status and future prospects.
    Archan S, Toller W.
    Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of levosimendan in healthy volunteers and patients with congestive heart failure.
    Sandell EP, Hayha M, Antila S, Heikkinen P, Ottoila P, Lehtonen LA, Pentikainen PJ.
    J Cardiovasc Pharmacol; 1995 Feb; 26 Suppl 1():S57-62. PubMed ID: 8907132
    [Abstract] [Full Text] [Related]

  • 18. European experience on the practical use of levosimendan in patients with acute heart failure syndromes.
    Follath F, Franco F, Cardoso JS.
    Am J Cardiol; 2005 Sep 19; 96(6A):80G-5G. PubMed ID: 16181827
    [Abstract] [Full Text] [Related]

  • 19. [Role of Levosimendan in intensive care treatment of myocardial insufficiency].
    Rehberg S, Ertmer C, Van Aken H, Lange M, Bröking K, Morelli A, Westphal M.
    Anaesthesist; 2007 Jan 19; 56(1):30-43. PubMed ID: 17131137
    [Abstract] [Full Text] [Related]

  • 20. Randomized clinical trials with levosimendan.
    Mebazaa A, Barraud D, Welschbillig S.
    Am J Cardiol; 2005 Sep 19; 96(6A):74G-9G. PubMed ID: 16181826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.